Navigation Links
The Olive Branch Fund Announces Funding Award to Harvard Researcher
Date:6/29/2011

NASHVILLE, Tenn., June 29, 2011 /PRNewswire-USNewswire/ -- The Olive Branch Fund: A Thisbe and Noah Scott Legacy, an organization dedicated to combating pediatric motor neuron diseases, today announced its first funding award to Kevin Eggan, Ph.D., Associate Professor of Stem Cell and Regenerative Biology at Harvard University.  The award will support Dr. Eggan's ongoing research investigating the neuromuscular system and the diseases that affect it.  Dr. Eggan is a leading researcher in motor neuron disease. He received the MacArthur Fellowship in 2006 and received the Presidential Early Career Award for Science and Engineering from President George Bush in 2008.

"This initial grant to Dr. Eggan is an incredibly exciting milestone for us as we begin to invest the funds we have raised to support the mission of The Olive Branch Fund and to advance groundbreaking research in the fight against motor neuron disease.  We are pleased this award will support Dr. Eggan's important research while also providing clues into the mechanisms of Brown-Vialetto-Van Laere syndrome," said Laurian Scott, Co-Founder of The Olive Branch Fund.  Brown-Vialetto-Van Laere syndrome is a rare, progressive, neurodegenerative motor neuron disorder that specifically includes palsies (paralysis) of the cranial nerves, and is sometimes referred to as "bulbar palsy."  Throughout the past century, few cases of Brown-Vialetto-Van Laere have been reported in the literature, but those numbers are growing.

The Olive Branch Fund: A Thisbe and Noah Scott Legacy was formed in 2008 to promote research, awareness, and support for families of all pediatric motor neuron diseases in memory of Laurian and John Scott's two children, Noah, who passed away at 19 months, and Thisbe, who passed away just before her third birthday.  Six cities nationwide, including Nashville, Memphis, Richmond, and Phoenix, have held fundraisers for The Olive Branch Fund, raising over $500,000.  These fundraisers are titled "A Mighty Voice" and aid The Olive Branch Fund in carrying out its mission worldwide.

The Olive Branch Fund: A Thisbe and Noah Scott Legacy is a component fund of the Community Foundation of Middle Tennessee.  For more information, please visit www.theolivebranchfund.org.


'/>"/>
SOURCE The Olive Branch Fund
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
2. New antioxidant compounds have been identified in foods such as olive oil, honey and nuts
3. Powered by olive stones? Turning waste stones into fuel
4. Rcadia COR Analyzer System Safely Rules Out Coronary Artery Disease in Main Coronary Arteries and Branch Vessels
5. Edwin Rivera-Martinez, Former Chief of the FDA’s International Compliance Branch, Joins PAREXEL Consulting Strategic Compliance Team
6. Pharma ChemOutsourcing Unveils 100 Pharma & Biotech Speaker Faculty for 2009 Conference September 14-16 in Long Branch, NJ
7. Stunning Attendance for ChemOutsourcing Show on September 8-9 in Long Branch, NJ
8. Verenium Announces Signing of Lease for New Office and Lab Space
9. Celladon Corporation Announces Publication of Advanced Heart Failure Clinical Trial Results With MYDICAR® Enzyme Replacement Therapy in the Journal Circulation
10. Scotland Announces Goal to Double Life Sciences Contribution to Scottish Economy by 2020 at BIO
11. PharmacoFore, Inc. Announces Appointment of Chief Medical Officer and Vice President of Intellectual Property
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... Newly created ... services and solutions to the healthcare market. The company's primary focus is on ... sales and marketing strategies that are necessary to help companies efficiently bring their ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... , June 23, 2016   Boston ... of novel compounds designed to target cancer stemness ... has been granted Orphan Drug Designation from the ... treatment of gastric cancer, including gastroesophageal junction (GEJ) ... inhibitor designed to inhibit cancer stemness pathways by ...
(Date:6/23/2016)... , June 23, 2016  The Prostate Cancer Foundation (PCF) is ... treatments and faster cures for prostate cancer. Members of the Class of 2016 ... countries. Read More About the Class of 2016 PCF ... ... ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing unparalleled ... medical LCD display is the latest premium product recently added to the range of ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/16/2016)... , May 16, 2016   EyeLock LLC , ... announced the opening of an IoT Center of Excellence ... and expand the development of embedded iris biometric applications. ... level of convenience and security with unmatched biometric accuracy, ... identity aside from DNA. EyeLock,s platform uses video technology ...
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
Breaking Biology News(10 mins):